CD8A and diabetes mellitus: We selected the RIP-gp transgenic mouse model expressing the LCMV glycoprotein in the pancreas to determine whether peptide vaccination in these mice could lead to effective antitumor CD8 T cell responses that could potentially lead to diabetes.